logo
Actress reveals how cancer test that saved her life led to surprising family discovery

Actress reveals how cancer test that saved her life led to surprising family discovery

Fox News2 days ago
Olivia Munn, who previously claimed that a breast cancer risk assessment test saved her life, announced on social media this week that it also saved her mother's life.
"My mother was diagnosed with breast cancer," the actress, 45, wrote in her caption.
"You may know that when I talk about my own battle with cancer, I bring up the Lifetime Risk Assessment test that saved my life. I never would've predicted it would save my mom's life as well."
While there are several risk assessment tools available to patients and physicians, the breast cancer risk assessment tool (BCRAT) is one of the most common, Fox News Digital previously reported.
The BCRAT is based on a statistical model known as the Gail Model.
It's named after Dr. Mitchell Gail, an NIH distinguished investigator at the National Cancer Institute, according to a National Cancer Institute (NCI) spokesperson.
The five-minute test helps predict a woman's risk of developing invasive breast cancer within the next five years, and up to 90 years of age, according to the NCI.
Just one year ago, Munn credited the test with prompting her to get a biopsy – even after mammograms and genetic testing came back negative.
The biopsy showed she had Luminal B cancer in both breasts.
Luminal B is an aggressive, fast-moving cancer.
The BCRAT calculates a woman's "absolute breast cancer risk."
On its website, the organization defines this as the "chance or probability of developing invasive breast cancer in a defined age interval."
The risk calculator considers factors including age, race, medical history and reproductive history.
It also looks at the family history of breast cancer among relatives like mothers, sisters and daughters.
Once the information is calculated, users are provided with a score.
Fox News Digital previously reported that a five-year risk score of 1.67% or more is considered high-risk. A healthcare provider may recommend certain medications to decrease the chances of developing cancer, according to Cleveland Clinic's website.
For more Health articles, visit www.foxnews.com/health
Dr. Nicole Saphier, M.D., board-certified breast imaging radiologist and associate professor at Memorial Sloan Kettering Cancer Center in New York City, recommends individual risk assessments to her referring clinicians and patients.
"Olivia Munn's doctor may have saved her life by doing so," Saphier previously said in a statement to Fox News Digital when news of Munn's diagnosis first broke in 2024.
"While a standard mammogram is sufficient for nearly half of all women, many others will benefit from adding an ultrasound or MRI based on breast density and various other factors that may make someone [a] higher risk [candidate]."
Less than 5% of all women diagnosed with breast cancer will have cancer in the contralateral (opposite) breast, according to Saphier.
"Olivia Munn was one of those rare cases," she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York
Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York

Yahoo

time30 minutes ago

  • Yahoo

Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York

Jul. 11—Gerard C. Murphy Gerry Murphy was born in Brooklyn, New York on May 14, 1947 and left this world on June 18, 2025 in Albuquerque, New Mexico. He graduated from Fordham College, Magna Cum Laude, with a B.A. in Mathematics, and also received an M.S. in Mathematics from Polytechnic Institute of New York where he completed all course work towards a Ph.D. He taught Math at the Hackley School in Tarry-town, New York from 1971 to 1990 where he became Chairman of the Department and was awarded the Wallace McLean Chair in Math and Science. He then taught Math at Albuquerque Academy from 1990 to 2011. He loved teaching, skiing, playing tennis, traveling, reading, taking photographs, music, and was a member of the Zen Buddhist community in New York. Gerry will always be remembered as smart and very funny. He will be greatly missed by his family and friends. He leaves behind his wife of 56 years, Doreen Mazza Murphy; his sister, Virginia Murphy of Durham, England and her family; and his brother-in-law, Tony Mazza and wife Mona Look-Mazza of Aspen, Colorado. He is the son of the late Francis Murphy and Dorothy Colvell Murphy and the nephew of the late Virginia Colvell, all of Brooklyn, New York. There will be a private graveside service at Gate of Heaven Cemetery in Hawthorne, New York.

Why Clover Health (CLOV) Shares Are Trading Lower Today
Why Clover Health (CLOV) Shares Are Trading Lower Today

Yahoo

time35 minutes ago

  • Yahoo

Why Clover Health (CLOV) Shares Are Trading Lower Today

Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 4.8% in the afternoon session after a filing revealed that the company's CEO, Wai Conrad, sold a portion of his holdings. According to a regulatory filing on July 11, 2025, CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8 for a total of approximately $49,561. The transactions were made at prices ranging from $3.25 to $3.27 per share. While the sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell a predetermined number of shares at a predetermined time, the news can still create unease among investors. Insider selling, even when planned, is often scrutinized by the market for any signals about a company's future prospects, contributing to negative pressure on the stock price. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Clover Health? Access our full analysis report here, it's free. Clover Health's shares are extremely volatile and have had 45 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Clover Health is down 7.2% since the beginning of the year, and at $2.91 per share, it is trading 39.7% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health's shares 5 years ago would now be looking at an investment worth $261.71. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Why Owens & Minor (OMI) Shares Are Sliding Today
Why Owens & Minor (OMI) Shares Are Sliding Today

Yahoo

time43 minutes ago

  • Yahoo

Why Owens & Minor (OMI) Shares Are Sliding Today

Shares of medical supply and logistics company Owens & Minor (NYSE:OMI) fell 3% in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. Additionally, ongoing U.S. policy headwinds aimed at lowering drug prices and specific corporate challenges, like those faced by UnitedHealth Group, further compounded the sector's decline. As a result, the Health Care SPDR ETF (XLV) fell 1.0%, underperforming even as major indices pared some losses. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Owens & Minor? Access our full analysis report here, it's free. Owens & Minor's shares are extremely volatile and have had 44 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Owens & Minor is down 37.3% since the beginning of the year, and at $8.06 per share, it is trading 51.1% below its 52-week high of $16.48 from July 2024. Investors who bought $1,000 worth of Owens & Minor's shares 5 years ago would now be looking at an investment worth $1,095. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store